QUEBEC CITY, May 1, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (AEZS) (TSX: AEZ) (the "Company") will announce its first quarter 2013 financial and operating results after market close on Tuesday, May 7, 2013. The Company will host a conference call to discuss these results on Wednesday, May 8, 2013, at 8:30 a.m., Eastern Time.
Participants may access the live webcast via the Company's website at www.aezsinc.com in the "Newsroom" section, or by telephone using the following numbers: in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191. A replay of the webcast will also be available on the Company's website for a period of 30 days.
The Company further announced that it will hold its Annual Shareholders Meeting also on Wednesday, May 8, 2013, starting at 10:30 a.m., Eastern Time, at the offices of Norton Rose Canada, 1 Place Ville Marie, Suite 2500, in Montreal, Canada.
About Aeterna Zentaris
Aeterna Zentaris is an oncology and endocrinology drug development company currently investigating treatments for various unmet medical needs. The Company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. For more information please visit www.aezsinc.com.
